We can talk about elevating the patient’s voice in clinical research, or we can listen. So let’s listen! In this clip, you’ll hear from both current and past clinical trial participants. They share their first encounters with clinical research and the reasons they decided to participate. This compilation is from a recent Velocity Participant Advisory … Read more
On May 30, Velocity welcomed former Surgeon General Jerome Adams, MD, MPH, to an internal presentation about the importance and direction of diversity in clinical trial inclusion, followed by a Q&A hosted by Paul Evans, President and CEO. The companywide meeting was the first of a three-part series that Velocity is hosting centered on inclusivity, … Read more
Velocity is using multimodal LLMs, like OpenAI’s GPT-4o and others, to enhance productivity. At the forefront of this shift is Raghu Punnamraju, Velocity’s Chief Technology Officer. In this article he shares his thoughts on the rapid evolution of LLMs, and how quickly new tools are being applied to improve quality and efficiency. We have been anticipating … Read more
Enjoy a virtual tour of Velocity’s Durham, NC site, which showcases many of the features and standard equipment present at Velocity sites worldwide. Standard Velocity site features: Private exam rooms Comfortable patient reception areas Facilities for extended-stay PK studies Ample parking Secure monitoring rooms and workstations equipped with phones and high-speed internet Individual and secure … Read more
“Next to clean water, vaccines are probably responsible for more saved lives than anything else we’ve done in medicine.” -Mark Turner, MD, Vaccine CARE Council Leader and Velocity Principal Investigator in Boise, ID. Given the constant evolution of viruses and the massive medical and economic burdens imposed by viral diseases, vaccine research remains a global … Read more
Beth Safirstein, MD, leads a site that was recently recognized by a top 10 pharma Sponsor as a leading U.S. enroller of diverse patients. As the chair of the CNS CARE Council, Dr. Safirstein is one of the expert Principal Investigators who will inform the way Velocity sites shape and share best practices to reach … Read more
In the second of two blogs in a collaborative series written by Paul Evans, President and CEO, and Victoria DiBiaso, Head, Patient Informed Development & Health Value Translation, Sanofi, they emphasize the most critical aspect of clinical trials — the patient. As we blaze a trail toward faster and more efficient clinical trials, it is … Read more
“Clinical research is really the only opportunity we have to give our patients some hope and some perspective that their disease will one day be treatable.” Nadege Gunn, MD, CPI, has consistently championed community engagement and physician referrals to drive successful clinical trial enrollment at her site in Waco, TX. As a MASH CARE Council … Read more
Congratulations to Paul Evans, President and CEO of Velocity, for being named one of the most influential life sciences business leaders in the state in Business North Carolina’s 2024 Power List! The list was compiled by BNC’s editorial team after seeking nominations, talking with dozens of sources, and performing extensive research. Well done, Paul! Read … Read more
Merck recently presented Velocity’s Hallandale Beach site with the Significant Contribution to Clinical Trials Award, specifically for being the top enroller of diverse participants in cardiovascular clinical trials in 2023. We’re grateful for the contributions of our Hallandale Beach site toward improving diversity in clinical trials, both in the workforce and in our participants. We’re … Read more